Associate Professor Dr. Chen Yeng is an expert in cancer biomarker discovery, biosensor development, and natural therapeutics, with a multidisciplinary approach that bridges nanotechnology, molecular biology, and biomedicine. Her expertise is particularly evident in her work on innovative diagnostic technologies and personalized therapeutic solutions, targeting both cancer and infectious diseases.  Her research interests span several cutting-edge areas. One of her primary focuses is the identification and characterization of cancer biomarkers, particularly through novel approaches targeting at immunogenic host proteins. This line of research explores how immunogenic proteins’ interventions might modulate cancer risk, representing an innovative intersection of microbiology, proteomics, and oncology.  Dr. Chen is also deeply engaged in developing advanced diagnostic tools, including nanobiosensors with enhanced sensitivity and specificity. These devices, designed to detect critical biomarkers such as those associated with tuberculosis, blood clotting disorders, and oral cancer, are transformative for early disease detection. Her work in biosensors, utilizing materials like gold nanoparticles and zinc oxide nanolayers, has set new standards in diagnostic accuracy and reliability.  Another cornerstone of her research is the study of natural plant extracts for therapeutic applications, particularly in cancer treatment. She investigates the biochemical and pharmacological properties of these extracts, focusing on their mechanisms of action, such as inducing apoptosis, causing cell cycle arrest, and promoting mitochondrial dysfunction in cancer cells. Her exploration of natural products' roles in modulating microRNAs further highlights her innovative approach to cancer research.  Dr. Chen’s expertise also extends to the antioxidant, hepatoprotective, and genoprotective properties of herbal compounds, offering potential preventive and therapeutic solutions for chronic diseases. These studies underline her commitment to sustainable and natural approaches in healthcare.  Her contributions to genomics and proteomics, particularly in large-scale screening for biological markers, further demonstrate her role as a leader in translating complex biological data into meaningful clinical applications. By combining her deep understanding of molecular biology with a focus on real-world impact, Dr. Chen has established herself as a pioneer in her field.  Dr. Chen’s academic influence is demonstrated by her impressive h-index of 28 (ResearchID) and 39 (Scopus), with over 4,500 citations to her name. Her extensive publication record spans high-impact journals, contributing significantly to advancements in dentistry, oncology, and biomedical engineering. She is recognized as a top scientist in Malaysia, ranking among the leading figures in dentistry according to the AD Scientific Index. As a respected peer reviewer for prestigious journals, including Coordination Chemistry Reviews, Periodontal 2000, Biosensors and Bioelectronics, and Cancer Letters, Dr. Chen plays a critical role in maintaining the quality of research within her fields of expertise. Her contributions extend to academic leadership, where she had supervised and graduated over 20 postgraduate students, including 11 PhD candidates, nurturing the next generation of scientific leaders. Her leadership in dental education accreditation has further solidified her impact on academic excellence. She has played pivotal roles in the reaccreditation of dental programs at the University of Malaya and other institutions, ensuring that these programs meet global standards. Through her commitment to interdisciplinary collaboration, Dr. Chen has partnered with industry leaders to translate research findings into practical healthcare solutions, such as rapid diagnostic tools and personalized treatments. These collaborations exemplify her ability to bridge scientific discovery with real-world applications. In summary, Dr. Chen’s expertise and research interests reflect a holistic approach to biomedical science, integrating cutting-edge technologies with sustainable practices. Her work not only pushes the boundaries of knowledge in cancer research and diagnostics but also has the potential to transform patient care and public health globally.

Dr. Che Chong Chin is a Senior Lecturer at the Department of Nursing Science, Faculty of Medicine, Universiti Malaya. She holds a PhD in Nursing Science from Universiti Malaya, along with a Master of Nursing (Education) and a Bachelor of Nursing from Monash University. With more than 30 years of combined academic and clinical experience, she is recognized as a committed scholar, educator, and advocate for advancing nursing education, practice, and research. Dr. Che’s pioneering work on the development of a time banking model has positioned her at the forefront of innovation in community health. Beyond this flagship initiative, she contributes to international efforts on environmental sustainability in healthcare through the Green-Care Toolkit and continues to advance psychosocial strategies for preventing healthcare-associated infections. A prolific researcher, she has published widely in WoS- and Scopus-indexed journals on caregiving, cancer survivorship, advance care planning, women’s health, and empowerment in vulnerable populations. Her article in the Journal of Advanced Nursing was recognized as one of the most highly cited in 2017. She also serves on the Editorial Advisory Board of Nursing Open, reviews for international journals, and is a life member of the Golden Key International Honour Society. As a dedicated educator and mentor, Dr. Che has nurtured the growth of many postgraduate students and remains deeply engaged in community health. Her vision is to drive research that not only advances academic knowledge but also transforms practice and informs policy.

Dr. Wahib M. Atroosh, hailing from Yemen, is a senior lecturer in the Department of Parasitology at Universiti Malaya (UM), where he has been a faculty member since 2019. He began his academic journey in the same department, completing his Master's degree in 2012, and subsequently pursued a PhD, which he earned with Distinction in 2017. Dr. Wahib's research focuses primarily on Plasmodium falciparum, the parasite responsible for the majority of severe malaria cases and deaths in humans, known for its high mortality rate and increasing resistance to antimalarial drugs. His expertise includes monitoring antimalarial drug resistance through in vivo clinical trials and the application of molecular gene markers of drug resistance. In addition to his primary research on malaria, Dr. Wahib collaborates with local and international research teams, including partnerships with the Medical Research Center at Jazan University in Saudi Arabia, the School of Biological Science at Universiti Sains Malaysia, and the College of Health Sciences, Nigeria. These collaborations explore the epidemiology, genotyping, and molecular characterization of antimalarial drug resistance in P. falciparum isolates from both Saudi Arabia and Nigeria. Dr. Wahib's contributions to the field of parasitology extend to other areas, including research on leishmaniasis, intestinal protozoa, schistosomiasis, soil-transmitted helminths (STH), and parasite-related health education programs. Dr. Wahib has also been involved in developing a novel gene marker aimed at differentiating P. falciparum isolates, enhancing the correctness of the malaria therapeutic efficacy studies outcome. Throughout his career at UM, Dr. Wahib has successfully secured internal and external research grants and contributed to 44 publications in indexed journals with an h-index of 18 and a total of 1,615 citations. He was also awarded the Universiti Malaya Excellent Service Award (APC) for the year 2023. Dr. Wahib actively contributes to the academic community as a member of scientific and technical committees and serves as a judge at international conferences. He is also a peer reviewer for several esteemed journals, including Scientific Reports, PLoS ONE, PLoS Neglected Tropical Diseases, Parasites & Vectors, Malaria Journal, Transactions of the Royal Society of Tropical Medicine and Hygiene, BMC Medicine, Pathogens and Global Health, and Tropical Biomedicine. His involvement in these roles underscores his commitment to advancing research and fostering collaboration in the field of parasitology.